Consumer News Can Mark Cuban’s Costplus Drugs Really Bring Down Drug Costs

Mark Cuban's Cost Plus Drugs, Humana exploring partnership to tackle employer drug costs

Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs for employers. | Mark Cuban's Cost Plus Drugs and Humana are exploring a ... Read More

Why Mark Cuban’s Drug Cost Message Resonates: It’s Simple

When Mark Cuban talks about how his Cost Plus Drugs company can reduce prescription costs, his message is simple. Read More

Mark Cuban: Employers Are Unknowingly Profiting From Sick Workers’ Drug Costs

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can violate fiduciary duties under ERISA. His company, Cost Plus Drugs, is ... Read More

Humana And Mark Cuban’s Cost Plus Drugs Working On Partnership To Lower Prices

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ... Read More

Is Mark Cuban Wrong About Employers, PBMs and Drug Prices?

From Left to Right: Arundhati Parmar, editor-in-chief, MedCity News; Dickon Waterfield, president, Lantern; Darcy Sementi, healthcare benefits manager, State Farm ... Read More

Mark Cuban launched an online pharmacy that promises lower prescription drug prices

The products and services mentioned below were selected independent of sales and advertising. However, Don't Waste Your Money may receive a small commission from the purchase of any products or ... Read More

Mark Cuban seeks Trump’s backing for drug fee relief to spur generics manufacturing

Billionaire Mark Cuban has urged the Trump administration to waive the hundreds of thousands of dollars in regulatory fees required for generic drug approvals, he told Reuters on Wednesday. Cost Plus ... Read More

Mark Cuban Cost Plus Drug Company Expands Access with Addition of Starjemza® (ustekinumab-hmny) to Give Patients More Power Over Prescription Costs

DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ... Read More

Mark Cuban implores employers to consider cash pay, simplify contracting

In a virtual fireside chat on Tuesday with Scripta Insights CEO Eric Levin, Mark Cuban spoke passionately about the potential of simplified contracting and cash pay. Scripta is a partner of Cuban’s ... Read More